REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $102,000 | -27.1% | 61,781 | 0.0% | 0.00% | – |
| Q4 2016 | $140,000 | -31.4% | 61,781 | 0.0% | 0.00% | – |
| Q3 2016 | $204,000 | +14.0% | 61,781 | 0.0% | 0.00% | – |
| Q2 2016 | $179,000 | -34.9% | 61,781 | +55.7% | 0.00% | – |
| Q1 2016 | $275,000 | -20.7% | 39,681 | 0.0% | 0.00% | – |
| Q4 2015 | $347,000 | +33.5% | 39,681 | 0.0% | 0.00% | – |
| Q3 2015 | $260,000 | -40.2% | 39,681 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $435,000 | +10.1% | 39,681 | +70.3% | 0.00% | 0.0% |
| Q1 2015 | $395,000 | +35.7% | 23,300 | +28.7% | 0.00% | – |
| Q4 2014 | $291,000 | +134.7% | 18,100 | 0.0% | 0.00% | – |
| Q3 2014 | $124,000 | -15.1% | 18,100 | 0.0% | 0.00% | – |
| Q2 2014 | $146,000 | -11.0% | 18,100 | 0.0% | 0.00% | – |
| Q1 2014 | $164,000 | +22.4% | 18,100 | 0.0% | 0.00% | – |
| Q4 2013 | $134,000 | -20.2% | 18,100 | 0.0% | 0.00% | – |
| Q3 2013 | $168,000 | -7.2% | 18,100 | 0.0% | 0.00% | – |
| Q2 2013 | $181,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |